SP-0202

N/A

Report date: 2026/05/23 20:00:57

Base Information

Drug NameSP-0202
Drug Alias NameNext Gen PCVNext-generation pneumococcal conjugate vaccinePneumococcal vaccine conjugateSP-0202GBP410 +[10] 
ClassificationVaccines > Vaccine type > Multivalent vaccineVaccines > Development/production technology > Conjugated vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsAnemia, Sickle CellRubellaMumps +[11] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumCanada +[19] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesSanofiSk Chemicals
China Registration ClassN/A

Develop Information

Active CompaniesSanofiSanofi PasteurSk Bioscience Co Ltd
Inactive CompaniesN/A
Active IndicationsAnemia, Sickle CellRubellaMumps +[11] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A